Health Care/Hospital APAC News & Press Release Distribution

Health Care/Hospital

All
Global

ZEISS Announces U.S. FDA Clearance of the QUATERA 700, a Revolution in Phaco Technology

The latest technology from ZEISS empowers surgeons with one complete, digitally integrated cataract workflow for efficiency without compromise. JENA, Germany and DUBLIN, Ireland, April 20, 2022 /PRNewswire/ -- Today, ZEISS Medical Technology announced the U.S. Food and Drug Administration (FDA) ...

2022-04-20 19:00 1859

ZEISS Announces U.S. FDA Clearance of the QUATERA 700, a Revolution in Phaco Technology

JW Therapeutics Announces IND Approval for the Clinical Trial of Carteyva® in Pediatric and Young Adult Patients with Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia

SHANGHAI, April 20, 2022 /PRNewswire/ -- JW Therapeutics (HKEx: 2126), an independent, innovative biotechnology company focused on developing, manufacturing and commercializing cell immunotherapy products, announced the Investigational New Drug (IND) clearance from the National Medical Products ...

2022-04-20 18:30 2400

Mentice's CEO Göran Malmberg to present the company's interim report at a webcast conference call on April 27 at 10:00 CEST

STOCKHOLM, April 20, 2022 /PRNewswire/ -- Mentice AB (STO: MNTC) announces that the company will present its interim report via webcast conference call with the opportunity for interested parties to ask questions to CEO Göran Malmberg and CFO Gunilla Andersson. To register for the presentation o...

2022-04-20 18:28 1539

SNIPR BIOME Initiates First-in-Human Clinical Trial with SNIPR001

COPENHAGEN, Denmark, April 20, 2022 /PRNewswire/ -- SNIPR BIOME ApS, a leading CRISPR and microbiome gene therapy biotechnology company, today announced dosing of the first human subjects in its phase 1 clinical trial with SNIPR001, an orally administered CRISPR-based therapeutic. The purpose of...

2022-04-20 14:04 1612

Fit Hub Further Commits to Democratize Fitness for Everyone by Expanding its Branches Across 15 Cities in Indonesia

Fresh funding enables Fit Hub to advance with online-to-offline business plan to address challenges in lower tier cities inIndonesia. JAKARTA, Indonesia, April 20, 2022 /PRNewswire/ -- A technology-driven health and wellness company based inIndonesia, Fit Hub, is expanding its offline fitness c...

2022-04-20 10:00 2743

Fit Hub Further Commits to Democratize Fitness for Everyone by Expanding its Branches Across 15 Cities in Indonesia

MILVIK BIMA RAISES FRESH INVESTMENT FOR DIGITAL HEALTH WALLET TECHNOLOGY

STOCKHOLM, LONDON and SINGAPORE, April 20, 2022 /PRNewswire/ -- MILVIK BIMA ("BIMA"), a leading digital healthcare solutions provider in emerging markets, has raised new funds from existing shareholders Allianz X and Leapfrog Investments to launch its Health Wallet inAsia.

2022-04-20 09:00 3961

MILVIK BIMA RAISES FRESH INVESTMENT FOR DIGITAL HEALTH WALLET TECHNOLOGY

Treadwell Therapeutics Announces the Appointment of J.D. Mowery, as Chief Operating Officer

NEW YORK and HONG KONG, April 20, 2022 /PRNewswire/ -- Treadwell Therapeutics (" Treadwell"), a clinical-stage biotechnology company developing novel, cross-modality medicines for unmet needs in cancer, announced today the appointment of J.D. Mowery as Chief Operating Officer (COO). Reporting into...

2022-04-20 04:30 1769

FIRST PATIENT WITH BASAL CELL CARCINOMA TREATED IN NEW FOCUSED ULTRASOUND STUDY: TOOsonix A/S

The dermatology departments at Bispebjerg and Roskilde Hospitals, University of Copenhagen, Denmark, initiate pioneering treatment of the world's most common cancer with a new convenient, minimal-pain and easy-to-operate modality for skin oncology. HOERSHOLM, Denmark, April 19, 2022 /PRNewswire...

2022-04-19 21:08 1966

Excelra Makes Strategic Investment in Anlitiks, a Disruptive HEOR and RWE Technology-led Consulting Company

HYDERABAD, India and BOSTON, Mass., April 19, 2022 /PRNewswire/ -- Excelra, a leading global Data and Analytics provider for Life Science organizations, has announced a strategic majority investment in Anlitiks, a young and rapidly growing technology company in the value and evidence domain. The...

2022-04-19 21:00 2638

Mission Bio Partners with S2 Genomics to Offer Robust Solid Tumor Sample Prep for Single-Cell DNA Analysis

MSKCC lab paired Tapestri and Singulator 100 to demonstrate automated nuclei extraction workflow for fast and reliable nuclei prep for single-cell DNA analysis SOUTH SAN FRANCISCO, Calif., April 19, 2022 /PRNewswire/ -- Mission Bio, Inc. , the pioneer in high-throughput single-cell DNA and multi-...

2022-04-19 20:00 1650

SMART Medical Systems' G-EYE® Colonoscope is now FDA Cleared on Olympus' PCF Colonoscope Series, Making it Available in the United States on the Commonly Used Models of All Leading Endoscopy Brands

- FDA has approved the use of G-EYE® with Olympus' 510(k) cleared PCF colonoscopes - RA'ANANA, Israel, April 19, 2022 /PRNewswire/ -- SMART Medical Systems Ltd., a developer and manufacturer of innovative endoscopy products, today announced an additional FDA clearance for its G-EYE® Colonoscope...

2022-04-19 20:00 1764

Novavax Announces Approval of Nuvaxovid™ COVID-19 Vaccine for Primary and Booster Immunization in Japan

* Nuvaxovid is the first protein-based COVID-19 vaccine approved for use in adults aged 18 and older inJapan * Approval is first in the world for NVX-CoV2373 that includes both primary and booster vaccination GAITHERSBURG, Md., April 19, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a bi...

2022-04-19 19:15 2213

Gastroenterology: NTC submits marketing authorisation application for KLEERKOL® in EU

MILAN, April 19, 2022 /PRNewswire/ -- NTC Srl, R&D driven pharmaceutical company with headquarters inItaly announces the submission of the marketing authorisation application through the European Decentralised Procedure (DCP) for its development product NTC015 (Kleerkol®) for bowel preparation fo...

2022-04-19 18:00 1740

Ascletis Announces 3CLpro Inhibitor ASC11 Demonstrated Potential to be Effective Treatment for COVID-19

- In antiviral cellular assays, antiviral potency (EC90) of ASC11 is 31-fold of that of Nirmatrelvir, 120-fold of that of S-217622, 16-fold of that of PBI-0451 and 7-fold of that of EDP-235. - ASC11 is an in-house discovered oral small molecule drug candidate, targeting 3CLpro, with global intel...

2022-04-19 16:50 2221

Translumina launches VIVO ISAR, its Dual-Drug Polymer-free Coated Stent (DDCS) in International markets

Launch of novel stent technology with 10-year safety and efficacy data adds further momentum to the company's global growth journey NEW DELHI and HECHINGEN, Germany, April 19, 2022 /PRNewswire/ -- Translumina, a global developer and manufacturer of innovative cardiovascular medical devices used...

2022-04-19 14:00 2147

Pondok Indah Hospital Group first in Indonesia to achieve HIMSS EMRAM Stage 6

JAKARTA, Indonesia, April 19, 2022 /PRNewswire/ -- HIMSS announced today that Pondok Indah Hospital Group has become the first healthcare provider inIndonesia to achieve Stage 6 on the HIMSS Electronic Medical Record Adoption Model (EMRAM). The eight-stage EMRAM measures clinical outcomes, patien...

2022-04-19 13:59 1918

GILEAD SCIENCES AND NATIONAL FOUNDATION OF DIGESTIVE DISEASES SET OUT TO STRENGTHEN LEARNING, ACCESS TO LIVER HEALTH EDUCATION IN SINGAPORE

-- Gilead Sciences supports National Foundation of Digestive Diseases with grant funding to improve liver health education inSingapore as part of its Asia Pacific ALL4LIVER Grant -- -- The National Foundation of Digestive Diseases gets digital upgrade to enhance liver health awareness and educa...

2022-04-19 11:00 1865

Proprietary SARS-CoV-2 3CL Inhibitor Rapidly Progressing in Clinical Trials, Market Approval of Trilaciclib Expected in China, Simcere Reveals Global Innovation Ambition on R&D Day

NANJING, China, April 19, 2022 /PRNewswire/ -- On April 15, 2022, Simcere Pharmaceutical (2096.HK), an innovation and R&D driven pharmaceutical company in China held its first R&D day for international investors, during which the executive leaders revealed Simere's R&D strategy, and gave an update...

2022-04-19 10:28 1821

MGI announces partnership with Nalagenetics to advance pharmacogenomics in Singapore and Indonesia

The partnership will address some critical issues in pharmacogenetic assay through sequencing workflows improvement SINGAPORE, April 19, 2022 /PRNewswire/ -- MGI, a company committed to being a world-leading life science innovator, today announced a partnership with Nalagenetics (NALA) to ...

2022-04-19 10:00 2621

Prioritizing Quality and Patient Satisfaction, Pondok Indah Hospital Group Achieves HIMSS EMRAM Stage 6, the First in Indonesia

JAKARTA, Indonesia, April 19, 2022 /PRNewswire/ -- Pondok Indah Hospital Group (Rumah Sakit Pondok Indah Group) continues to carry out digital transformation through optimization, efficiency, and continuous integration efforts, consistent with the hospital group commitment to providing the best h...

2022-04-19 09:00 2227

1 ... 208 209 210211212 213 214 ... 553